Impact of the COVID-19 Controlled Drugs and Substances Act exemption on pharmacist prescribing of opioids, benzodiazepines and stimulants in Ontario: a cross-sectional time-series analysis
Chang A, Chaudhry S, McCormack D, Gomes T, Shivji A, Tadrous M. Can Pharm J (Ott). 2022; Oct 12 [Epub ahead of print].